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There has been growing concern regarding
the widespread exposure of the Bangladeshi
population to arsenic in tube-well water
(Smith et al. 2000). Many interventions and
alternative water sources have been advocated
on the grounds that they are effective in
reducing arsenic ingestion. However, limited
consideration has been given to possible
adverse effects of such interventions, in par-
ticular, water-related infectious diseases such
as diarrhea. Although this issue has been
raised (Caldwell 2003; MacDonald 2001),
there has been no evaluation published allow-
ing a meaningful assessment of the competing
risks involved in mitigation. Such an assess-
ment is required before the development of
effective policy recommendations for arsenic
mitigation in Bangladesh.
In this article, we present an evaluation of
the possible change in overall burden of disease
resulting from implementation of arsenic
mitigation interventions in Bangladesh and
compare likely impacts on both arsenic-
related disease and water-borne infectious
disease. 
Materials and Methods
Arsenic-related disease due to chronic exposure
through drinking water has a relatively low
incidence and a latency of up to decades for
most end points signiﬁcant to a burden of dis-
ease assessment (National Research Council
2001). However, case fatality rates for arsenic-
exposure–related sequelae such as internal can-
cer are high, particularly in a country such as
Bangladesh where access to health care is lim-
ited. In contrast, diarrheal and other water-
related infectious diseases, although having a
comparatively low case fatality rate, have a
much higher incidence. Additionally, 90% of
the disease burden due to diarrhea occurs in
children younger than 5 years of age (Pruss
et al. 2002), unlike arsenic, which affects pri-
marily older adults. To provide a basis for com-
paring end points with such diversity in the
population proﬁle, we calculated mortality rates
and disability-adjusted life years (DALYs) lost
for end points related to these two risk factors.
DALYs are the measure used by the
Global Burden of Disease (GBD) study to
assess and compare burden of disease due to
varied risk factors and end points. The DALY
is a summary health measure that accounts for
mortality at different ages and for both the
severity and duration of morbidity (Murray
et al. 2002). By using DALYs, a comparison
can also be made between the impacts of
arsenic, of water-related infection, and of
arsenic mitigation interventions overall, with
other causes of disease in Bangladesh evalu-
ated by the GBD study. DALYs, which mea-
sure loss of healthy life, are useful for assessing
the impact of interventions and comparing
predicted health states (Murray and Acharya
1997); therefore, we chose DALYs over other
measures of quality-adjusted life. Because one
purpose of the present study was to provide
input into policies for arsenic mitigation, we
include estimates discounted at 3% (the 
discounting rate used in the standard GBD 
ﬁgures) alongside those with zero discounting.
The disease burden attributable to each
risk factor was estimated using cause-speciﬁc
rates of mortality and DALYs for the Southeast
Asia region (SEAR), D subregion, for the year
2001 published in the 2002 World Health
Report [World Health Organization (WHO)
2002]. These estimates were regarded as the
most appropriate for Bangladesh because the
SEAR-D subregion includes those countries
within the SEAR that have high child and
adult mortality rates (India, Bangladesh, and
Pakistan).
To calculate disease burden for those end
points not disaggregated in the GBD study,
we obtained background mortality rates
applicable to the Bangladeshi population from
the literature. These data were then entered
into the formulas for DALYs given in the GBD
study (Murray and Lopez 1996). The rates of
disease and assumptions used for each speciﬁc
exposure and sequelae are deﬁned below.
We obtained demographic data from mul-
tiple sources. Total population by thana-level
administrative unit was obtained from the
Bangladesh Bureau of Statistics and derived
from the 1991 national census (Bangladesh
Bureau of Statistics 2002). The age structure of
the Bangladeshi population was obtained from
the 1999–2000 Bangladesh Demographic and
Health Survey (BDHS) (National Institute of
Population Research and Training 2001).
Relative risk estimates from published liter-
ature were entered into the formulas for attrib-
utable fraction given by Rockhill et al. (1998).
The calculated exposure and disease-specific
attributable fractions were then applied to rele-
vant background estimates to obtain the total
disease burden due to the factors under study.
Disease burden from arsenic exposure. We
calculated estimates of the arsenic-exposed
population by different age strata by assuming
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lar age structure to the population surveyed in
the 1999–2000 BDHS (National Institute of
Population Research and Training 2001);
b) total population numbers within each
thana subunit were similar to those of the
1991 national census; and c) exposure was
through use of water from shallow tube wells.
Population estimates were adjusted for levels
of shallow tube-well use, currently estimated
at 87% (Caldwell 2003).
Data on arsenic levels in tube wells used
in this study were obtained from a British
Geological Survey (BGS) survey of tube wells
in Bangladesh (Kinniburgh and Smedley
2001). This survey is the only one currently
published that provides nationally representa-
tive data. Table 1 shows the average and
median arsenic concentrations for various
ranges calculated using these data.
We calculated the population exposed to
arsenic at different levels by using the distrib-
ution of arsenic exposure estimated from the
BGS data (Kinniburgh and Smedley 2001).
and applying it to 1991 national census data
(Bangladesh Bureau of Statistics 2002). This
was done for each thana, the smallest admin-
istrative subunit for which data were available.
The calculated proportions of the population
in each exposure strata are shown in Table 2.
Arsenic-related end points. The quality of
studies detailing associations between health
outcomes and arsenic exposure varies. The
literature has been reviewed by expert commit-
tees from the U.S. Environmental Protection
Agency (EPA) Science Advisory Board (U.S.
EPA 2001a), in the 2001 United Nations
Synthesis Report on Arsenic in Drinking Water
(Abernathy 2001), and by the American
Council on Science and Health (Brown and
Ross 2002). Table 3 stratiﬁes the level of evi-
dence for a possible association between arsenic
and these disease end points according to these
key reviews. From those end points that any of
these organizations considers to have strong or
reasonably strong evidence for an association,
we selected all that directly contribute to disease
burden. We included lung, bladder, kidney,
and skin cancers; ischemic heart disease; and
diabetes mellitus.
End points not included. Skin alterations
are the most common manifestation of
chronic arsenic exposure. However, as in the
GBD study, the nonmalignant manifestations
were assumed to cause minimal disability and
no independent increase in mortality; there-
fore, we did not include nonmalignant skin
alterations as end points in our study.
Peripheral vascular disease (PVD) has been
noted in arsenic-exposed populations world-
wide, but there is continuing debate over the
association between arsenic and the more
severe forms of PVD, in particular, the role of
other chemicals in the causation of blackfoot
disease (Yang et al. 2002). For this reason, and
because it has not been noted in Bangladesh,
PVDs such as blackfoot disease were not
included.
Although hypertension has been found to
be associated with arsenic exposure (Rahman
et al. 1999), it is not a contributor to disease
burden of itself, but a risk factor for end points
that have been included. Hypertension was
therefore not included as a separate end point.
Calculating arsenic-related attributable
fraction of disease. Although there are some
studies on arsenic-related disease in Bangladesh,
none provide reliable population-level estimates
of risk. Despite limitations, and uncertainty
regarding the level of exposure, the data we
used were from studies carried out in Taiwanese
populations (Tsai et al. 1999). We used these
data because they are still recognized as the
most reliable source of dose–response informa-
tion on exposure to arsenic in drinking water
currently available (National Research Council
2001; U.S. EPA 2001b).
Cancers associated with arsenic. Relative
risks for lung, liver, bladder, and kidney cancer
were published in a review by Smith et al.
(1992). A major issue related to the use of
these estimates was the wide range within
each category of exposure. In particular, the
lowest exposure group covered the range from
0 to 300 µg/L [weighted average concentra-
tion, 170 µg/L (U.S. EPA 1988)]. However,
the average concentration in tube wells in
Bangladesh for this range is much lower:
170 µg/L is closer to the average concentra-
tion in tube wells in Bangladesh in a range of
100–300 µg/L and not 0–300 µg/L (Table 1).
Most studies also suggest that the threshold
for internal malignancies related to arsenic
exposure is > 100 µg/L (Chiou et al. 2001;
Guo 2000). The risks for the Taiwanese popu-
lation exposed at an average concentration of
170 µg/L are therefore probably most applica-
ble to the population in Bangladesh exposed
within the 100–300 µg/L range. To account
for this, we calculated a range of attributable
fractions, each using the same relative risk for
the lowest exposure category, but with the
proportion of the population exposed to that
risk level varied to the proportion in
Bangladesh exposed at 0–30, 10–300, 50–300,
or 100–300 µg/L.
We applied the relative risks due to arsenic
exposure obtained from these Taiwanese data
to estimates of DALYs and deaths for each end
point in the GBD SEAR-D subregion (WHO
2002). However, the GBD study does not pro-
vide disaggregated data for either kidney or
nonmelanotic skin cancer. In the case of kid-
ney cancer, we calculated mortality using age-
speciﬁc background cancer mortality rates in
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Table 1. Arsenic concentrations in tube wells in
Bangladesh.
Average Median
Concentration concentration concentration
range (µg/L) within range (µg/L) within range (µg/L)
0–300 33 < 10
10–300 82 56
50–300 132 108
100–300 180 170
> 300–600 421 406
> 10–500 107 63
> 500 628 572
> 50–500 167 130
> 600 755 668
Calculated using data from Kinniburgh and Smedley
(2001).
Table 2. Distribution of arsenic exposure across
the population of Bangladesh.
Arsenic Percentage of population
concentration exposed to drinking water
range (µg/L) contaminated at this level
≤ 10 58.8
> 10–50 16.4
> 50–100 8.6
> 100–300 10.9
> 300–600 4.5
> 600 0.83
Calculated using BGS tube-well survey data (Kinniburgh
and Smedley 2001) and population data from the 1991
Bangladesh national census (Bangladesh Bureau of
Statistics 2002).
Table 3. Strength of evidence for a causal link between arsenic and various end points.
Reference Level of evidence Exposure-related disease end point
U.S. EPA 2001a Strong Lung, bladder cancer
Reasonably strong Ischemic heart disease, diabetes mellitus,
hypertension, skin cancer
Suggestive Prostate cancer, nephritis and nephrosis, hypertensive
heart disease, nonmalignant respiratory disease
Abernathy 2001 Strong Skin, lungs, bladder, kidney cancer, skin 
hyperkeratosis and pigmentation changes
Reasonably strong Hypertension, cardiovascular disease
Suggestive Diabetes, reproductive diseases
Weakest Cerebrovascular disease, long-term neurologic effects, 
cancer at sites other than skin, lung, bladder, and 
kidney
Brown and Ross 2002 May cause Skin, lung, bladder cancer, cutaneous effects
Possible Kidney, liver, prostate, and other cancers
Some evidence Cardiovascular/cerebrovascular diabetes,
reproductive diseasesBangladesh published by the International
Agency for Research on Cancer (IARC; Ferlay
et al. 2001). For Bangladesh, where cancer
registry data are not available, mortality was
estimated from Indian registry incidence data
using country/regional survival (Parkin 1986).
However, the background rate we used for
kidney cancer is actually an aggregate of kid-
ney cancer along with cancers of other urinary
organs and therefore will overestimate the risk
of kidney cancer alone.
There are no reliable estimates for either
incidence or case fatality rates for nonmelanotic
skin cancers applicable to Bangladesh. Arsenic
is not associated with melanoma, which domi-
nates the estimates from the combined skin
cancer categories routinely reported, including
by IARC; therefore these rates could not be
used. By combining calculated lifetime excess
risk of skin cancer due to arsenic exposure in
Bangladesh (Khan et al. 2003) with a case
fatality rate of 14.3% for arsenic-related skin
cancers over a 5-year period (Yeh 1973), it was
possible to derive an estimate of the number
of skin cancer deaths per year due to arsenic
exposure in Bangladesh.
For both skin cancer and kidney disease,
lack of data meant that only total mortality
and years of life lost (YLL), a subcomponent
of DALYs, could be calculated.
Noncancer effects associated with arsenic.
Several studies have noted an association
between arsenic exposure and cardiovascular
disease in populations from Taiwan, Chile,
and the United States, and an increased
prevalence of hypertension has been noted in
populations exposed to arsenic, including in
Bangladesh (Rahman et al. 1999). Three pos-
sible sources of risk estimates were a cohort
study by Chen et al. (1996), an ecologic level
study by Tsai et al. (1999), and a study in
Bangladesh on prevalence of hypertension
(Rahman et al. 1999). Chen et al. (1996) were
unable to provide precise estimates of risk at
levels of exposure < 500 µg/L. We did not use
the Rahman et al. (1999) study because expo-
sure was not directly determined but inferred
from the presence of arsenic-related skin
lesions. The relative risk of death from
ischemic heart disease in arsenic-exposed
compared with nonexposed populations was
therefore obtained from Tsai et al. (1999).
Diabetes has also been associated with
arsenic exposure in some studies, including one
conducted in arsenic-exposed populations in
Bangladesh (Rahman et al. 1998), but again,
this study suffered from the same limitations of
exposure measurement. The ecologic study by
Tsai et al. (1999) on the Taiwanese population
found standardized mortality ratios (SMRs) for
death from diabetes of 1.35 for women and
1.55 for men in a population exposed to ele-
vated arsenic levels in drinking water compared
with a local reference population; we used
these ﬁgures to calculate attributable risk.
Water-related infectious diseases. There are
several infectious diseases that are water related,
including infective causes of acute diarrhea,
helminth infections, schistosomiasis, and
water-washed diseases such as trachoma (Esrey
et al. 1991). Within the SEAR-D subregion as
a whole, > 99% of the disease burden from
these infections is attributable to diarrheal dis-
ease. Pruss et al. (2002) estimated that the
global disease burden due to diarrhea and other
water-related infectious diseases attributable to
water, sanitation, and hygiene is 4.0% of all
deaths and 5.7% of the total burden of disease
in DALYs lost. Proportionately, diarrheal dis-
ease is an even greater contributor to the bur-
den of disease in developing countries such as
Bangladesh (Hussain et al. 1999). Considering
that the overall burden of diarrheal disease is so
high, it is important to evaluate the possible
impacts that currently recommended changes
in water supply aimed at arsenic mitigation
may have on water-related infectious disease, in
particular, diarrheal disease.
Attributable risk due to change in water
supply. In the context of Bangladesh, the
most appropriate technology in terms of
microbiologically clean water was and is tube
wells. To assess the possible additional burden
of disease resulting from changes to current
arsenic-contaminated water supplies, it is nec-
essary to estimate the magnitude of this effect.
A recent study into the global burden of
water-related illness disease categorized expo-
sure to diarrheal disease from water supply into
several levels (Pruss et al. 2002). The Global
Water Supply and Sanitation Assessment
classiﬁcation of water supplies and sanitation
infrastructure was the source of the defini-
tions used by Pruss et al. (2002) to categorize
the exposure level of subgroups of the world
population in terms of access to water and
sanitation services [WHO and the U.N.
Children’s Fund (WHO/UNICEF) 2002].
Levels of relevance to this assessment and the
risk reduction when moving between these
levels for the present study are presented in
Table 4. 
A recent WHO/UNICEF joint report
(WHO/UNICEF 2001) used serial surveys of
coverage to estimate current levels of access to
water supply and sanitation in Bangladesh.
Access to improved sanitation in rural areas is
41%; therefore, 59% of the population has
inadequate access to these services (WHO/
UNICEF 2001).
The current status of most of the
Bangladeshi population would primarily be
within the Vb level of risk (improved water
supply but no improved sanitation; Table 4).
In evaluating possible arsenic mitigation
options, the feasible alternatives include vari-
ous forms of surface water, treatment of tube-
well water before consumption, and the use of
available uncontaminated tube wells. All
involve a possible change in either the quality
or quantity of water available to the household
for use.
A transition to surface water sources such
as unimproved dug wells, ponds, or streams
would mean a change in exposure status from
level Vb to level VI (no improved water supply
and no sanitation) and therefore an estimated
increase in diarrheal disease of 20%. The data
presented below are based on the assumption
of the equivalent of this change in risk for
arsenic mitigation interventions for those in
the subpopulation without access to improved
sanitation.
Mortality due to diarrheal disease.
Although several studies in Bangladesh have
examined diarrheal incidence in childhood,
relatively few have assessed mortality. Because
reliable estimates require large sample sizes,
most studies evaluating diarrheal mortality do
so in the context of hospital-based case studies
and cannot provide estimates of overall mor-
tality in the community.
One extensive source of data on Bangladesh
comes from studies conducted in the long-term
follow-up area of the International Center for
Diarrhoeal Disease Research, Bangladesh
(ICDDR-B; Fauveau 1994). However, this
population has been studied intensively over
many decades and may not therefore be rep-
resentative of the general population. In the
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Table 4. Change in risk of diarrheal disease due to improvements in water supply and sanitation services.
Risk
Level Description of level difference
VI No improved water supply and no basic sanitation in a country Index
that is not extensively covered by those services, and where
water supply is not routinely controlled
Vb Improved water supply and no basic sanitation in a country that 20.8%
is not extensively covered by those services, and where water
supply is not routinely controlled
Va Basic sanitation but no improved water supply in a country that 37.5%
is not extensively covered by those services, and where water
supply is not routinely controlled
IV Improved water supply and basic sanitation in a country that is 37.5%
not extensively covered by those services, and where water
supply is not routinely controlled
Data from Pruss et al. (2002).present study, we used the GBD SEAR-D
water-related infectious disease morbidity rates
(WHO 2002), which are conservative relative
to ICDDR-B estimates.
Results
Table 1 gives the average and median arsenic
concentrations for various ranges of exposure,
calculated using BGS tube-well survey data
from Bangladesh (Kinniburgh and Smedley
2001).
Table 2 details the proportion of popu-
lation estimated to be within each exposure
range in those regions of Bangladesh surveyed
by the BGS (Kinniburgh and Smedley 2001).
Table 5 provides results of the estimated
total burden of disease due to exposure to
arsenic at concentrations > 50 µg/L.
Projections of intervention impact on
water-related infectious disease are shown in
Table 6, given that 59% of the population in
Bangladesh does not have access to improved
sanitation and assuming that interventions
are used by all those exposed to > 10 µg/L
(scenario A) or all those exposed to > 50 µg/L
(scenario B).
Projections of the net change in disease bur-
den as a result of intervention are shown in
Table 7. These projections assume a 100%
reduction in arsenic-related disease, along with
a 20% increase in water-related infectious dis-
ease in the subgroup without access to sanita-
tion. Also included is an estimate of the net
effect with different thresholds for the effects of
arsenic on lung, bladder, and kidney cancer.
Table 8 presents the predicted increase in
infectious disease burden as a percentage of
current total arsenic-related disease burden and
is therefore the minimum reduction in current
arsenic-related disease burden necessary to
achieve any net decrease in overall disease bur-
den through intervention.
Table 9 presents the arsenic-related burden
of disease in those exposed to concentrations
>5 0µ g/L as a proportion of total burden of
disease in Bangladesh and as a proportion of
the disease burden due to other selected causes.
Discussion
Arsenic contamination of drinking water is a
major health issue for those living in affected
areas of Bangladesh. However, the present
study demonstrates that much of the beneﬁt
obtained from intervention may be negated
by a concomitant increase in water-related
infectious disease. Currently, in the evalua-
tion of arsenic mitigation interventions, the
emphasis is on assessing their impact on
arsenic levels. Clearly this is important because
inefﬁcient interventions are likely to have little
overall beneﬁt and may even have adverse net
impacts. However, all suggested mitigation
interventions must be considered not only
from the perspective of reducing arsenic-related
morbidity and mortality but also from the
overall health perspective.
There are a number of methodologic
issues that are important in considering the
results of the present study: a) estimates of
exposure; b) estimates of disease burden from
arsenic exposure, in particular the end points
chosen for inclusion; c) extrapolation of risk
estimates of arsenic exposure from different
populations, with differing exposure levels;
d) estimates of the effectiveness of arsenic mit-
igation interventions; e) estimates of disease
burden from diarrhea; and f) estimates of diar-
rheal risk from arsenic mitigation interven-
tions, including assumptions about changing
from improved to unimproved water supplies.
Estimates of exposure. Exposure data were
obtained from the BGS survey of tube wells
(Kinniburgh and Smedley 2001), the only
nationally representative data on tube-well
contamination currently available. However,
this survey sampled fewer than 4,000 tube
wells; therefore, at the thana level, exposure
was inferred from relatively few data points.
These estimates can be refined only if more
comprehensive tube-well surveys, using
nationally representative sampling frames, are
conducted.
Estimates of disease burden from arsenic
exposure. We took an inclusive approach in
estimating the disease burden from arsenic
exposure. The GBD rates for cardiovascular
disease and diabetes may be an overestimate for
Bangladesh because members of this primarily
poor and rural population are likely to have
lower cardiovascular disease and diabetic mor-
tality rates than those in the urban Indian
populations, whose levels are more likely to
match the SEAR-D estimates (WHO 2002).
The disease burden due to these end points is
therefore likely to be biased toward a beneﬁcial
effect of arsenic mitigation. The burden of dis-
ease estimates for arsenic are dominated by the
contribution of cardiovascular disease, but the
association between arsenic exposure and
cardiovascular disease remains ambiguous, at
least in strength of association. Because the
strength of this association will determine
whether interventions are likely to cause good
or harm, it is crucial that valid estimates of this
association are available, particularly at lower
arsenic exposure levels.
End points resulting from chronic arsenic
exposure chosen for inclusion were those that
major reviews considered to have strong or
reasonably strong evidence of a causal link.
Numerous other end points have been found
to be associated with arsenic exposure.
However, the evidence is much less deﬁnitive,
in terms of both whether an association exists
and its strength. Additionally, data do not
currently exist to allow a meaningful estimate
of the burden of disease resulting from such
end points. However, excluding them from
this study may slightly underestimate arsenic-
related burden of disease.
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Table 5. Burden of disease incurred in Bangladesh each year due to arsenic levels > 50 µg/L.
DALYs
Disease Deaths Undiscounted Discounted at 3%
Diabetes mellitus 351 10,524 7,628
Ischemic heart disease 5,128 91,616 67,380
Tracheal, bronchial, lung cancers 2,100 39,759 28,921
Bladder cancer 1,346 25,432 17,121
Kidney cancera 85 3,463 1,840
Skin cancera 126 3,379 2,120
Total disease burden 9,136 174,174 125,010
aIncludes only YLL and not years lived with disability.
Table 6. Estimated increase in water-related infectious disease burden caused by arsenic mitigation.
DALYs
Scenario Deaths Undiscounted Discounted at 3%
A: Assuming interventions were used by  3,370 218,198 97,659
all those exposed to arsenic > 10 µg/L
B: Assuming interventions were used by  2,080 134,671 60,275
all those exposed to arsenic > 50 µg/L
Table 7. Net impact of arsenic mitigation on burden of disease in Bangladesh.
Threshold for
Population supplied arsenic-related lung, DALYs
with intervention bladder, and kidney cancer Deaths Undiscounted Discounted at 3%
All those exposed to No threshold 6,623 –27,251 39,173
arsenic levels > 10 µg/L > 50 µg/L 5,765 –44,024 27,351
> 100 µg/L 5,072 –58,785 17,324
All those exposed to No threshold 7,055 39,503 64,735
arsenic levels > 50 µg/L > 100 µg/L 6,362 24,741 54,707
A negative number signiﬁes a net overall increase in DALYs lost.Extrapolation of risk estimates of arsenic
exposure from different populations with differ-
ing exposure levels. For all arsenic-related end
points, we derived risk estimates from a differ-
ent population to the study population, assum-
ing the same exposure–risk relationship. The
source Taiwanese population is described as
being largely rural, engaged in farming, ﬁshing,
and salt production, of below average socio-
economic standard, and with a low-protein diet
based primarily on rice and sweet potatoes (Wu
et al. 1989). In terms of these factors, the cur-
rent Bangladeshi population is fairly similar to
the Taiwanese population of 40 years ago from
which the data are derived (Bangladesh Bureau
of Statistics 2002). The primary caloric source
is rice, and malnutrition levels are high (Ahmed
1992). For these reasons, we made no adjust-
ment for fluid intake and body mass, as has
been done when extrapolating Taiwanese data
to the U.S. population (Morales et al. 2000).
However, the risks for the Taiwanese popula-
tion exposed at an average concentration of
170 µg/L (range, 0–300 µg/L) are probably
most applicable to the population in
Bangladesh exposed within the 100–300 µg/L
range and not the 0–300 µg/L range (discussed
in “Materials and Methods”).
Estimates of the effectiveness of arsenic
mitigation interventions. Arsenic mitigation
interventions, if given to those exposed to
>5 0µ g/L, would need to achieve at least a
77% reduction in arsenic-related disease bur-
den to result in a net reduction in DALYs.
Arsenic mitigation interventions cannot
achieve a 100% reduction in disease burden
for several reasons, and even reductions of
70–80% are doubtful. It is unlikely that any
of the interventions widely accessible in
Bangladesh would be 100% effective, due to
both compliance and efﬁcacy, and the degree
to which arsenic contamination of irrigation
water and resultant intake through food con-
tributes to disease burden is unclear.
Therefore, assuming a 100% reduction in
arsenic-related disease after intervention, as was
done for all estimates in this study, is likely to
bias results toward a beneﬁcial outcome from
intervention.
Estimates of disease burden from diarrhea.
The GBD study rates (WHO 2002) used in
the estimations are lower than those from
recent studies in Bangladesh on the disease
burden from diarrhea; Streatﬁeld et al. (2001)
estimated the disease burden attributable to
diarrheal disease in Bangladesh as 11% of all
deaths and 12.1% of DALYs. The SEAR-D
rates used (WHO 2002) were 6.2% of deaths
and 7.2% of undiscounted DALYs, which are
both almost half that of Streatfield et al.
(2001). The background rates of diarrheal dis-
ease used are therefore conservative in the con-
text of Bangladesh. This is again likely to bias
results toward an overall beneficial effect of
arsenic mitigation.
Estimates of diarrheal risk from arsenic
mitigation interventions. The association
between incidence of diarrheal disease and
water supply was categorized into several levels
by Pruss et al. (2002). Based on these data,
there is a 20.8% increase in risk when moving
between level Vb (improved water supply but
no basic sanitation) to level VI (no improved
water supply and no basic sanitation). Studies
conducted in developing countries including
Bangladesh found that water and sanitation
interventions have a proportionately greater
impact on child mortality as opposed to mor-
bidity [a 26% reduction in morbidity, com-
pared with a 55% reduction in overall
mortality, and a 65% reduction in diarrhea
related mortality (Esrey et al. 1991)]. Because
the attributable risks used applied to changes in
morbidity, it is likely that we underestimated
impacts on mortality.
It is clearly appropriate to assume an
increased risk when the intervention involves
moving from tube wells to dug wells that are
not sanitary protected (constructed to be rela-
tively protected from microbial contamina-
tion), or moving to other forms of surface
water that are unimproved. However, a
change from contaminated water to unconta-
minated tube wells would, at face value,
appear to involve no change in exposure status.
Assuming any individual household would
prefer to use the most convenient well, usually
the closest and often within the household
compound, any change in the tube well would
presumably involve a change to an uncontami-
nated but less convenient tube well, in terms of
either distance or the number of individuals
using the well for water. Aside from compli-
ance issues, this also increases the risk of water-
borne disease. Studies have found that in terms
of protection against infectious disease, the
quantity of water used is as important or even
more important than the quality of water used
(Esrey et al. 1991), and that the quantity of
water used is directly related to the distance to
the water source and the number of users
(Hoque et al. 1989). Thus, even a change in
the tube well used may increase the risk of
diarrheal disease.
There is also evidence to suggest that
arsenic ﬁltration systems may increase the risk
of water-related infections. The main risk of
filter systems is through increased handling
and storage of water within the household,
and past studies have shown that household
storage and handling is a signiﬁcant source of
contamination, perhaps the major source
(Molbak et al. 1989). This assumption is sup-
ported by a field study evaluating arsenic
removal systems in Bangladesh, which found
that such systems had higher levels of micro-
bial contamination in the ﬁltrated water than
in the tube wells from which the water was
taken (Sutherland et al. 2002) and may there-
fore increase the risk of water-related infectious
disease.
Latency. Any impact that changes in water
supply have on incidence of arsenic-related
disease will be delayed, probably for several
years. Estimates of the latency period for
arsenic-related chronic disease vary greatly, but
most are in the range of several decades. For
bladder, lung, and liver cancer, estimates range
to > 40 years (Chen et al. 1986). However, the
impact of arsenic mitigation interventions on
diarrheal disease will be immediate. Because
maximal arsenic-related reductions would be
delayed for a number of years, there would be
an overall increase in mortality in the period
immediately after initiation of any interven-
tion. Because the results given here apply only
once equilibrium has been reached, they do
not take into account this period and there-
fore, again, are biased toward a beneficial
effect of mitigation.
Conclusions
There are many areas where limited data
affected the validity of the estimates obtained
in this study, including lack of data on the
long-term effects of arsenic exposure at the
lower ranges; lack of reliable population-level
estimates of risk related to arsenic exposure in
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Table 8. Predicted increase in infectious disease burden resulting from arsenic mitigation, given as a per-
centage of the disease burden currently incurred through arsenic exposure.a
DALYs (%)
Population supplied with intervention Deaths (%) Undiscounted Discounted at 3%
Exposed to arsenic levels > 10 µg/L 34 114b 71
Exposed to arsenic levels > 50 µg/L 23 77 48
aAssuming no threshold for arsenic-related disease. bPercentage is > 100 because the total arsenic-related burden of disease
that can be removed through mitigation is less than that predicted due to water-related infectious disease after mitigation.
Table 9. Current disease burden due to arsenic levels > 50 µg/L as a proportion of burden of disease due to
other selected causes in Bangladesh.
DALYs (%)
Disease Deaths (%) Undiscounted Discounted at 3%
All causes 0.9 0.3 0.4
Childhood-cluster diseases 34.2 8.1 14.7
Nutritional deﬁciencies 71.0 12.0 15.8Article | Effect of arsenic interventions on disease burden
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Bangladesh, particularly for those more
common end points such as cardiovascular
disease that are likely to constitute the bulk of
disease burden; and imprecise data on exposure
nationally.
At present, there are inadequate data to
reliably meet these needs, and formulating pol-
icy options before the availability of such data
carries potentially signiﬁcant risks. The present
study is an attempt to make a quantitative
assessment of the impacts of intervention. As
data become available in those areas where it is
currently lacking, further refinements will
allow more precise estimates of benefit and
risk.
As Table 9 demonstrates, arsenic-related
disease resulting from exposure to arsenic
concentrations > 50 µg/L constitutes 0.3% of
the total disease burden in Bangladesh in
terms of undiscounted DALYs, and although
it is a significant cause of disease burden in
exposed groups, nationally it is of less impor-
tance than many other risk factors.
Interventions must be used effectively in a
country such as Bangladesh, where resources
are limited and multiple competing interests
exist. In the case of arsenic mitigation, this
means ensuring that interventions are targeted
to those areas where exposure has been con-
ﬁrmed, and that those interventions provided
achieve signiﬁcant reductions in arsenic expo-
sure without concomitantly causing substantial
increases in other risks such as water-related
infectious disease.
As these estimates demonstrate, the effects
of arsenic mitigation are double-edged, and
intervention appears to be clearly justiﬁable at
present only within the higher levels of expo-
sure. There is an urgent need for studies evalu-
ating alternative water sources in terms of not
only their effectiveness in reducing arsenic
intake but also their associated effect on water-
related infections.
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